Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Inhibition of DYRK1A proteolysis modifies its kinase specificity and rescues Alzheimer phenotype in APP/PS1 mice.
Acta Neuropathol Commun. 2019 Mar 18;7(1):46. doi: 10.1186/s40478-019-0678-6.
Acta Neuropathol Commun. 2019.
PMID: 30885273
Free PMC article.
Alzheimer's disease-like APP processing in wild-type mice identifies synaptic defects as initial steps of disease progression.
Audrain M, Fol R, Dutar P, Potier B, Billard JM, Flament J, Alves S, Burlot MA, Dufayet-Chaffaud G, Bemelmans AP, Valette J, Hantraye P, Déglon N, Cartier N, Braudeau J.
Audrain M, et al. Among authors: dufayet chaffaud g.
Mol Neurodegener. 2016 Jan 12;11:5. doi: 10.1186/s13024-016-0070-y.
Mol Neurodegener. 2016.
PMID: 26759118
Free PMC article.
Item in Clipboard
Genetically modified macrophages accelerate myelin repair.
Aigrot MS, Barthelemy C, Moyon S, Dufayet-Chaffaud G, Izagirre-Urizar L, Gillet-Legrand B, Tada S, Bayón-Cordero L, Chara JC, Matute C, Cartier N, Lubetzki C, Tepavčević V.
Aigrot MS, et al. Among authors: dufayet chaffaud g.
EMBO Mol Med. 2022 Aug 8;14(8):e14759. doi: 10.15252/emmm.202114759. Epub 2022 Jul 13.
EMBO Mol Med. 2022.
PMID: 35822550
Free PMC article.
Item in Clipboard
Cite
Cite